MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 97 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $372,000 | -41.9% | 146,559 | +129.1% | 0.18% | +166.7% |
Q3 2018 | $640,000 | -17.7% | 63,966 | -41.8% | 0.07% | -90.4% |
Q2 2018 | $778,000 | +153.4% | 109,991 | +36.8% | 0.69% | +158.6% |
Q1 2018 | $307,000 | -0.3% | 80,389 | +112.7% | 0.27% | -31.1% |
Q4 2017 | $308,000 | – | 37,803 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 3,977,453 | $15,194,000 | 8.96% |
Granite Point Capital Management, L.P. | 2,638,321 | $10,078,000 | 0.98% |
New Leaf Venture Partners, L.L.C. | 342,550 | $1,309,000 | 0.71% |
683 Capital Management, LLC | 1,200,000 | $4,584,000 | 0.40% |
Virtus ETF Advisers LLC | 80,389 | $307,000 | 0.27% |
Iguana Healthcare Management, LLC | 100,000 | $382,000 | 0.25% |
THREE BAYS CAPITAL LP | 944,300 | $3,607,000 | 0.25% |
Granite Point Capital Management, L.P. | 549,900 | $2,101,000 | 0.20% |
Cormorant Asset Management, LP | 478,111 | $1,826,000 | 0.14% |
GMT CAPITAL CORP | 2,533,798 | $9,680,000 | 0.12% |